Stock ALK B ALK-ABELLÓ A/S
Add to a list
To use this feature you must be a member
Log inSign up

Calendar ALK-Abelló A/S

Equities

ALK B

DK0061802139

Market Closed - Nasdaq Copenhagen
Other stock markets
 15:59:59 26/04/2024 BST 		5-day change 1st Jan Change
130 DKK +4.50% Intraday chart for ALK-Abelló A/S +3.50% +28.46%
03-14 Transcript : ALK-Abelló A/S - Shareholder/Analyst Call
03-04 New entries in MarketScreener's Europe portfolio Our Logo

Chart calendar ALK-Abelló A/S

d20bfe8dc0714bbbb3eeec96b52af._AyKXPQY5wL0fq1l2jlt_9BhTjGE-zbBdVzmX2VkpGo.yWizFo1wjnSNNc5dlA8AnolXKRzyykzzTGmfKToC4SzNYf82q3K0S7kclQ~ff01cd83351e830f010c5dc65488e603

Upcoming events on ALK-Abelló A/S

02/05/2024 Q1 2024 Earnings Release
03/05/2024 11:30 Q1 2024 Earnings Call
03/06/2024 Capital Markets Day
22/08/2024 Q2 2024 Earnings Release
13/11/2024 Q3 2024 Earnings Release
10/02/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)
12/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)

Past events on ALK-Abelló A/S

14/03/2024 15:00 Annual General Meeting
08/02/2024 15:00 Q4 2023 Earnings Call
08/02/2024 12:35 Q4 2023 Earnings Release
06/12/2023 Nordic American Healthcare Conference
21/11/2023 SEB Healthcare Seminar
15/11/2023 Roadshow
15/11/2023 12:30 Q3 2023 Earnings Call
15/11/2023 06:30 Q3 2023 Earnings Release
10/09/2023 Morgan Stanley Global Healthcare Conference
24/08/2023 12:30 Q2 2023 Earnings Call
24/08/2023 06:30 Q2 2023 Earnings Release
31/05/2023 05:00 ABGSC Life Science Summit
09/05/2023 12:30 Q1 2023 Earnings Call
09/05/2023 06:20 Q1 2023 Earnings Release
23/03/2023 15:00 Annual General Meeting
03/02/2023 13:00 FY 2022 Earnings Call
03/02/2023 11:07 FY 2022 Earnings Release
16/11/2022 Investor Meeting
10/11/2022 12:30 Q3 2022 Earnings Call
10/11/2022 06:30 Q3 2022 Earnings Release

Past dividends on ALK-Abelló A/S

15/03/2017 Annual 5 DKK
10/03/2016 Annual 5 DKK
12/03/2015 5 DKK

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK		Released
Forecast
Spread 		3 274
3 268
0.19%		3 491
3 509
-0.52%		3 916
3 886
0.76%		4 511
4 457
1.22%		4 824
4 832
-0.17%
5 350

EBITDA
Million DKK		Released
Forecast
Spread 		241
242
-0.39%		395
393
0.63%		534
529
0.98%		708
698
1.5%		911
934
-2.43%
1 274

EBIT
Million DKK		Released
Forecast
Spread 		-14,0
-21,4
34.73%		150
161
-6.77%		292
276
5.77%		470
460
2.28%		666
682
-2.37%
1 005

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		-31,0
-31,3
0.92%		101
139
-27.59%		279
260
7.18%		447
444
0.66%		647
673
-3.92%
994

Net income
Million DKK		Released
Forecast
Spread 		-50,0
-46,9
-6.55%		25,0
73,3
-65.88%		219
189
15.82%		335
338
-0.98%		486
508
-4.3%
760

EPS
DKK		Released
Forecast
Spread 		-0,23
-0,21
-7.94%		0,11
0,33
-65.53%		0,99
0,85
16.25%		1,51
1,52
-0.65%		2,20
2,30
-4.23%
3,52

Announcement Date05/02/2010/02/2108/02/2203/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million DKK		Released
Forecast
Spread 		1 099
1 069
2.77%		1 155
1 132
2.08%		1 045
964
8.38%		1 062
1 032
2.86%		1 249
1 199
4.16%		1 234
1 244
-0.84%		1 135
1 114
1.93%		1 110
1 110
0.03%		1 345
1 352
-0.48%
1 353


1 246


1 237


1 517

EBITDA
Million DKK		Released
Forecast
Spread 		136
131
3.55%		272
244
11.36%		107
76,5
39.83%		128
92,6
38.28%		201
198
1.38%		288
312
-7.64%		157
145
8.28%		208
161
29.6%		258
289
-10.57%
363


235


289


406

EBIT
Million DKK		Released
Forecast
Spread 		79,0
62,0
27.42%		215
177
21.49%		49,0
10,6
362.8%		68,0
39,6
71.88%		138
126
9.23%		228
246
-7.48%		97,0
73,9
31.26%		147
98,2
49.77%		194
210
-7.62%
293


164


219


335

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		74,0
55,0
34.55%		217
179
21.46%		56,0
8,16
586.68%		70,0
37,3
87.73%		104
94,6
9.95%		217
248
-12.33%		89,0
76,0
17.11%		155
90,0
72.22%		186
231
-19.48%
291


147


206


317

Net income
Million DKK		Released
Forecast
Spread 		76,0
41,3
83.87%		163
133
22.33%		42,0
-0,88
4850.27%		52,0
27,8
86.78%		78,0
83,2
-6.3%		163
186
-12.2%		66,0
52,0
26.92%		117
74,3
57.58%		140
162
-13.31%
215


120


161


250

EPS
DKK		Released
Forecast
Spread 		0,35
0,19
82.7%		0,74
0,59
25.92%		0,19
-0,02
1050%		0,23
0,12
96.01%		0,35
0,38
-8.12%		0,70
0,84
-16.64%		0,30
0,28
7.14%		0,50
0,30
66.67%		0,70
0,77
-9.09%
0,97


0,54


0,72


1,13

Announcement Date08/02/2212/05/2211/08/2210/11/2203/02/2309/05/2324/08/2315/11/2308/02/24----

Upcoming sector events for ALK-Abelló A/S

28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
28/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
28/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for ALK-Abelló A/S

26/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
26/04/2024 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
26/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
26/04/2024 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
26/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
26/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
26/04/2024 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
26/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
26/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALK B Stock
  4. Calendar ALK-Abelló A/S